Key terms
About LGND
Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in Jupiter, FL.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest LGND news
Mar 08
8:45am ET
Ligand Pharma (LGND) Gets a Buy from Craig-Hallum
Mar 06
4:55am ET
Ligand management to meet with Craig-Hallum
Mar 02
1:06am ET
Ligand Pharmaceuticals Inc’s New Competition Risk – A Cause for Worry?
Mar 01
11:04am ET
Biotech Alert: Searches spiking for these stocks today
Feb 29
10:57am ET
Biotech Alert: Searches spiking for these stocks today
Feb 29
10:57am ET
Biotech Alert: Searches spiking for these stocks today
Feb 29
6:30am ET
Analysts’ Top Healthcare Picks: Ligand Pharma (LGND), Springworks Therapeutics (SWTX)
Feb 28
7:32am ET
Analysts Offer Insights on Healthcare Companies: Fulcrum Therapeutics (FULC), Ligand Pharma (LGND) and Alphatec Holdings (ATEC)
Feb 28
3:40am ET
Analysts Have Conflicting Sentiments on These Healthcare Companies: Ligand Pharma (LGND), Agilent (A) and Eli Lilly & Co (LLY)
Feb 27
1:07pm ET
Ligand management to meet with Craig-Hallum
Feb 27
7:13am ET
Ligand sees FY24 EPS $4.25 -$4.75, consensus $4.27
Feb 27
7:11am ET
Ligand reports Q4 EPS $1.38, consensus 66c
Feb 26
3:45am ET
Ligand Pharma (LGND) Receives a Buy from Barclays
Feb 23
9:03am ET
Analysts Offer Insights on Healthcare Companies: Ligand Pharma (LGND) and Celcuity (CELC)
Feb 22
4:13pm ET
Ligand partner Eisai receives Japan approval for Fycompa injection
Jan 29
5:06am ET
Barclays Remains a Buy on Ligand Pharma (LGND)
Jan 08
6:30am ET
Analysts Offer Insights on Healthcare Companies: Ligand Pharma (LGND), Neurogene (NGNE) and Gossamer Bio (GOSS)
Jan 05
4:31pm ET
Ligand announces FDA approval of ZELSUVMI
Dec 18
9:31am ET
Analysts’ Opinions Are Mixed on These Healthcare Stocks: NeuroOne Medical Technologies (NMTC), Invivyd (IVVD) and Ligand Pharma (LGND)
Dec 13
10:35am ET
Ligand Pharma: A Buy Rating on Strong Growth Prospects and Transition to Royalty Aggregation Model
Dec 13
7:20am ET
Analysts Offer Insights on Healthcare Companies: Genmab (GMAB), Ligand Pharma (LGND) and Syndax Pharmaceuticals (SNDX)
Dec 12
12:04pm ET
Ligand sees FY28 adjusted EPS $10.00-$10.50
Dec 12
12:02pm ET
Ligand sees FY24 adjusted EPS $4.25-$4.75, consensus $4.17
Dec 12
9:15am ET
Sermonix Pharmaceuticals shares PK, baseline data tied to Lasofoxifene trials
No recent news articles are available for LGND
No recent press releases are available for LGND
LGND Financials
Key terms
Ad Feedback
LGND Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
LGND Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range